Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
ARTICLE | Emerging Company Profile

BigHat: AI for antibody optimization beyond target engagement

Emerging Company Profile: $19M a16z-led round to support antibody optimization platform

By Sandi Wong, Assistant Editor
February 11, 2021 1:31 AM UTC

BigHat, which raised $19 million in an A round led by Andreessen Horowitz on Wednesday, is marrying lab assays with machine learning to optimize antibodies for properties beyond target engagement. 

The San Carlos, Calif.-based company’s three seed investors, 8VC, AME Cloud Ventures and Innovation Endeavors, invested in the untranched, oversubscribed financing...

Get Unlimited Access
Continue reading with a free trial.
Start a Free TrialLog In
Or Purchase This Article